The Open UniversitySkip to content
 

OECD International Futures Project on “The Bioeconomy to 2030: Designing a Policy Agenda”. Health Biotechnology to 2030

Tait, Joyce; Wield, David; Bruce, Ann and Chataway, Joanna (2007). OECD International Futures Project on “The Bioeconomy to 2030: Designing a Policy Agenda”. Health Biotechnology to 2030. OECD, Paris, France.

Full text available as:
[img]
Preview
PDF (Not Set) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (520kB)
URL: http://www.oecd.org/document/56/0,3343,en_2649_368...
Google Scholar: Look up in Google Scholar

Abstract

This is a report commissioned by the OECD.
Innogen was asked to write a scenario report for the OECD International Futures Programme to consider the pathways that health biotechnologies could follow, the future trajectory of the bio-economy primarily in the context of human health and the likely societal, economic and policy impacts of these projected outcomes, focusing on the period 2015 to 2030 . We chose as a starting point a world health care system that, from the perspective of potential impacts of biotechnology, has been mainly under the influence of the innovation model of the multinational drug companies. To date the scope and inventiveness of this model has been constrained by the expensive and lengthy regulatory systems that act as a barrier to entry for small companies that could challenge the industry status quo and our report focuses on the need for regulatory change as a prelude to the emergence of a new, more radically innovative, health care sector.


In the absence of such change our scenario predicts a health care sector that is increasingly populated by pharmaceutical commodity producers, research and development focused on incremental, piecemeal change, lack of both public and private sector funding, dysfunctional competition within and between companies and adversarial relationships with regulators.


A radical change scenario on the other hand “Networked Health Care” would depend on regulatory agencies collaborating, as an integral component of the innovation system, in the proactive development of new, smarter regulatory approaches to the generation of benefits based on fundamental discoveries in life sciences.


Our report describes the pre-conditions needed to lead to the more positive scenario and the roles of key actors in promoting or resisting such changes.

Item Type: Other
Copyright Holders: 2007 OECD International Futures Programme
Project Funding Details:
Funded Project NameProject IDFunding Body
Not SetNot SetOECD
Academic Unit/School: Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies > Development
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies
Faculty of Arts and Social Sciences (FASS)
Research Group: Innovation, Knowledge & Development research centre (IKD)
Institute for Innovation Generation in the Life Sciences (Innogen)
Related URLs:
Item ID: 12081
Depositing User: Jo Chataway
Date Deposited: 22 Oct 2008 05:38
Last Modified: 07 Aug 2019 01:26
URI: http://oro.open.ac.uk/id/eprint/12081
Share this page:

Download history for this item

These details should be considered as only a guide to the number of downloads performed manually. Algorithmic methods have been applied in an attempt to remove automated downloads from the displayed statistics but no guarantee can be made as to the accuracy of the figures.

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU